Accepted abstracts will be published in the journal Neuromuscular Disorders, on condition that the presenting author is registered for the Congress upon abstract submission. The journal issue will be given to all delegates attending the Congress upon arrival at the registration desk in Mendoza.
Abstracts are published in the journal which comes out around the time of the congress and may be online even 10 days beforehand. Elsevier oversee this schedule, not WMS.
- Opening of Abstracts submission: December 2017.
- The presenting author has to be registered in order to be able to submit an abstract.
- To submit an abstract the author will have to enter a specific code in the submission form. The code is to be found in the registration confirmation email in RED text.
- Abstracts must be submitted electronically no later than midnight on 9th April 2018 (GMT).
- Only the presenting author can be the submitter of an abstract. An abstract submitted by someone who is not the presenter will be refused.
- A maximum of 20 co-authors per abstract are allowed.
- Abstracts cannot be submitted by fax, hard copy or e-mail.
- Acknowledgement of receipt of the submission will be sent to the stated e-mail address.
- The presenting author will receive all correspondence concerning the abstract and is responsible for informing co-authors of the status of the abstract.
- The presenting author will have access to the abstract after submission via an online Personal Page (see below).
- In cases where the abstract is NOT accepted, participants will be contacted promptly and the registration fee fully reimbursed.
- The Programme Committee reserves the right to shorten the abstract title to allow its publication in the Conference Programme and Neuromuscular Disorders, and edit the content to remove acknowledgements and misspellings identified by the Programme Committee.
- Notification for abstracts will be sent out at the end of May/ beginning of June, after the programme meeting.
- Notification of fellowships will be sent out at the end of May/ beginning of June, after the programme meeting.
- Abstracts must be written in English.
- Maximum 2,000 characters (including spaces and excluding title and contact information on authors).
- There is a restriction of 20 co-authors for each abstract. If more co-authors have contributed, these should be summarily stated as Study Group and can later be displayed on the poster or appropriately be acknowledged during an oral.
- References and credits are not to be included in the abstract, nor subheadings or keywords.
- Note that all subheadings in abstracts automatically will be cancelled by the programme committee.
- It is the author’s responsibility to submit a correct abstract; if accepted any errors in spelling, grammar, or scientific fact will be reproduced as typed by the author.
- Upon submission, indicate one of the following topics that best describes the content of the abstract:
- New developments in genetic and acquired disorders of the neuromuscular junction.
- Mitochondrial function and dysfunction in neuromuscular disorders: pathogenesis and therapies.
- Advances in the treatment of neuromuscular disorders
Contributions will also be welcome on new advances across the neuromuscular field.
ABSTRACT SUBMISSION NOW CLOSED
- Accepted poster presenters are requested to prepare 3-5 PowerPoint slides in case the poster is selected for a flash poster presentation at the congress.
- Accepted poster presenters should include their email address on the poster so that interested people can reach them during the congress.
When the abstract is submitted the author can follow the progress online by entering his/her Personal Page for abstracts.
The Personal Page for abstracts makes it possible for the author to:
- Make changes until submission deadline (9th April 2018 GMT)
- Read and print the abstract
- The author will be able to access the Personal Page for abstracts by entering the personal user ID and password indicated in the attached file received in the confirmatory email after submission before the abstract submission deadline. After this date it is not possible to access the Personal Page.
For any questions regarding abstracts please contact: firstname.lastname@example.org